GLP Indication #1 : Balancing guidelines and individualized treatment

GLP Indication #1 : Balancing guidelines and individualized treatment “Should physicians rigidly adhere to treatment guidelines or prioritize accommodating patient preferences?” Join hosts Bradley Nelson and Tom Davies, alongside RxBenefits clinical pharmacist Langley Kyle, PharmD, as they discuss balancing GLP-1 treatment guidelines with individualized patient care, particularly for those with comorbidities, as well as the evolution of GLP-1s and their impact. In this episode, the team explores how GLP-1 medications have transformed diabetes treatment over the past decade, including offering patients more convenient dosing options. They discuss practical strategies for plan sponsors to support medication adherence and lifestyle changes in support of disease management. And tackle an important issue that can result from class popularity – drug shortages. Guest: Langley Kyle, PharmD, Director, Clinical Services Co-hosts: Bradley Nelson, PharmD, Vice President, Clinical Services Tom Davies, PharmD, Vice President, Clinical Products